Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

NCT07089420 is registered in ClinicalTrials.gov with American Laboratory Products Company as lead sponsor.

NCT NCT07089420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
Lead sponsor
American Laboratory Products Company
Phase
Observational
Overall status
Completed
Start date
July 7, 2025
Completion date
April 15, 2026
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), ibd (inflammatory bowel disease), ibs - irritable bowel syndrome, uc - ulcerative colitis